Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan
- PMID: 17650346
- PMCID: PMC1945025
- DOI: 10.1186/1471-2474-8-70
Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan
Abstract
Background: Malignant melanoma occurs infrequently in Taiwan. Once it has progressed into osseous metastases, the prognosis is poor. There are no reported clinical experiences of surgical management in this area.
Methods: To improve our understanding of the rare clinical experiences, we retrospectively investigated clinical characteristics, radiological findings, treatment modalities, survival outcomes and prognoses of 11 Taiwanese patients with osseous metastasis of melanoma treated surgically at two national medical centers, National Taiwan University Hospital and National Cheng Kung University Hospital from January 1983 to December 2006.
Results: Six patients suffered from acral-lentiginous melanoma. Nine patients sustained multiple osseous metastases and most lesions were osteolytic. Nine patients also had sustained metastases to other organs including liver, lungs, lymph nodes, brain and spleen. Second malignancies including lung cancer, thyroid papillary carcinoma, renal cell carcinoma and cervical cancer co-existed in four patients. The interval from the initial diagnosis of melanoma to the clinical detection of osseous metastases varied from 0-37.8 months (mean 9.75 months). Metastatic melanoma was invariably fatal; the mean survival time from bone metastases to death was 5.67 months.
Conclusion: Due to the high morbidity and poor survival of Taiwanese patients with osseous metastases of melanoma, surgical treatment should be directed towards pain relief and the prevention of skeletal debilitation in order to maintain their quality of life.
Figures



Similar articles
-
Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients.J Exp Clin Cancer Res. 2001 Mar;20(1):11-5. J Exp Clin Cancer Res. 2001. PMID: 11370816
-
Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.Niger Postgrad Med J. 2013 Mar;20(1):45-51. Niger Postgrad Med J. 2013. PMID: 23661210
-
Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.Surg Gynecol Obstet. 1979 Nov;149(5):687-92. Surg Gynecol Obstet. 1979. PMID: 505243
-
A rational surgical approach to the treatment of distant melanoma metastases.Cancer Treat Rev. 2008 Nov;34(7):614-20. doi: 10.1016/j.ctrv.2008.05.003. Epub 2008 Jun 16. Cancer Treat Rev. 2008. PMID: 18556133 Review.
-
Cutaneous melanoma: Taiwan experience and literature review.Chang Gung Med J. 2010 Nov-Dec;33(6):602-12. Chang Gung Med J. 2010. PMID: 21199605 Review.
Cited by
-
Cutaneous malignant melanoma "recurred as" or "in coexistence" with meningioma?Surg Neurol Int. 2010 Oct 6;1:60. doi: 10.4103/2152-7806.70853. Surg Neurol Int. 2010. PMID: 20975977 Free PMC article.
-
Operative management of metastatic melanoma in bone may require en bloc resection of disease.Clin Orthop Relat Res. 2014 Oct;472(10):3196-203. doi: 10.1007/s11999-014-3761-0. Epub 2014 Jul 3. Clin Orthop Relat Res. 2014. PMID: 24989125 Free PMC article.
-
Solitary secondary malignant melanoma of clavicle two years after enuclation for ocular melanoma.Case Rep Orthop. 2013;2013:591679. doi: 10.1155/2013/591679. Epub 2013 Jan 28. Case Rep Orthop. 2013. PMID: 23424696 Free PMC article.
-
Extra-Axial Skeletal Metastasis of Malignant Melanoma: Case Report and Literature Review.Cureus. 2022 Feb 11;14(2):e22115. doi: 10.7759/cureus.22115. eCollection 2022 Feb. Cureus. 2022. PMID: 35308763 Free PMC article.
-
Incidence, Risk Factors, and Survival of Bone Metastases and Skeletal-Related Events in Melanoma Patients: A Systematic Review and Quality Assessment of 29 Studies.J Bone Oncol. 2024 Apr 22;46:100603. doi: 10.1016/j.jbo.2024.100603. eCollection 2024 Jun. J Bone Oncol. 2024. PMID: 38765703 Free PMC article. Review.
References
-
- Atkins MB. The treatment of metastatic melanoma with chemotherapy and biologics. Curr Opin Oncol. 1997;9:205–213. - PubMed
-
- Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 1995;181:193–201. - PubMed
-
- Brochez L, Naeyaert JM. Understanding the trends in melanoma incidence and mortality: where do we stand? Eur J Dermatol. 2000;10:71–75. - PubMed
-
- Jemal A, Siegel R, Samuels A, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical